These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22219431)

  • 1. Iodine pleurodesis--a word of caution.
    Wong RH; Ng CS; Underwood MJ
    Eur J Cardiothorac Surg; 2012 May; 41(5):1209. PubMed ID: 22219431
    [No Abstract]   [Full Text] [Related]  

  • 2. Pleurodesis for recurrent malignant pleural effusions: the quest for the Holy Grail.
    Astoul P
    Eur J Cardiothorac Surg; 2011 Aug; 40(2):277-9. PubMed ID: 21194963
    [No Abstract]   [Full Text] [Related]  

  • 3. Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion.
    Ibrahim IM; Dokhan AL; El-Sessy AA; Eltaweel MF
    J Cardiothorac Surg; 2015 May; 10():64. PubMed ID: 25947235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local iodine pleurodesis versus thoracoscopic talc insufflation in recurrent malignant pleural effusion: a prospective randomized control trial.
    Mohsen TA; Zeid AA; Meshref M; Tawfeek N; Redmond K; Ananiadou OG; Haj-Yahia S
    Eur J Cardiothorac Surg; 2011 Aug; 40(2):282-6. PubMed ID: 20961772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of comparison of efficacy and safety of talc and povidone iodine for pleurodesis of malignant pleural effusions.
    Das SK; Saha SK; Das A; Halder AK; Banerjee SN; Chakraborty M
    J Indian Med Assoc; 2008 Sep; 106(9):589-90, 592. PubMed ID: 19552086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the pleurodesis potential of talc, iodpovidone, doxacycline and silver nitrate in experimental and clinical conditions in patients with malignant pleural effusions.
    Yankulov AD
    Folia Med (Plovdiv); 2013; 55(2):82-3. PubMed ID: 24191403
    [No Abstract]   [Full Text] [Related]  

  • 7. Iodopovidone: an inexpensive and effective agent for chemical pleurodesis.
    Agarwal R
    Lung Cancer; 2007 Feb; 55(2):253-4. PubMed ID: 17118489
    [No Abstract]   [Full Text] [Related]  

  • 8. Pleurodesis with povidone iodine in patients with malignant pleural effusion in a tertiary center in Nigeria.
    Omoregbee BI; Okugbo S
    Pan Afr Med J; 2021; 38():169. PubMed ID: 33995776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of iodopovidone versus bleomycin in chemical pleurodesis.
    Bagheri R; Noori M; Rajayi M; Attaran D; Mohammad Hashem Asna Ashari A; Mohammadzadeh Lari S; Basiri R; Rezaeetalab F; Afghani R; Salehi M
    Asian Cardiovasc Thorac Ann; 2018 Jun; 26(5):382-386. PubMed ID: 29792037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodopovidone as a pleurodesis agent: setting standards for clinical pleural research.
    Diacon AH
    Respirology; 2010 Jan; 15(1):4-5. PubMed ID: 20199631
    [No Abstract]   [Full Text] [Related]  

  • 11. Pleurodesis.
    Lamb C; Li A; Thakkar D; Lee P
    Semin Respir Crit Care Med; 2019 Jun; 40(3):375-385. PubMed ID: 31525812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study.
    Janssen JP; Collier G; Astoul P; Tassi GF; Noppen M; Rodriguez-Panadero F; Loddenkemper R; Herth FJ; Gasparini S; Marquette CH; Becke B; Froudarakis ME; Driesen P; Bolliger CT; Tschopp JM
    Lancet; 2007 May; 369(9572):1535-1539. PubMed ID: 17482984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Success rate of medical thoracoscopy and talc pleurodesis in malignant pleurisy: A single-centre experience.
    Leemans J; Dooms C; Ninane V; Yserbyt J
    Respirology; 2018 Jun; 23(6):613-617. PubMed ID: 29320805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodopovidone pleurodesis: experience of a tertiary hospital in Kolkata.
    Dey A; Bhuniya S; Datta Chaudhuri A; Pandit S; Saha-Dutta Chowdhury M; Sengupta A; Saha I; De P
    Singapore Med J; 2010 Feb; 51(2):163-5. PubMed ID: 20358157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14).
    Boshuizen RC; Vd Noort V; Burgers JA; Herder GJM; Hashemi SMS; Hiltermann TJN; Kunst PW; Stigt JA; van den Heuvel MM
    Lung Cancer; 2017 Jun; 108():9-14. PubMed ID: 28625655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleurodesis for malignant pleural effusion: talc, toxicity and where next?
    Davies HE; Lee YC; Davies RJ
    Thorax; 2008 Jul; 63(7):572-4. PubMed ID: 18587029
    [No Abstract]   [Full Text] [Related]  

  • 17. Talc pleurodesis through indwelling pleural catheters for malignant pleural effusions: retrospective case series of a novel clinical pathway.
    Ahmed L; Ip H; Rao D; Patel N; Noorzad F
    Chest; 2014 Dec; 146(6):e190-e194. PubMed ID: 25451360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of pleurodesis.
    Rodriguez-Panadero F; Montes-Worboys A
    Respiration; 2012; 83(2):91-8. PubMed ID: 22286268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Counterpoint: should thoracoscopic talc pleurodesis be the first choice management for malignant pleural effusion? No.
    Light RW
    Chest; 2012 Jul; 142(1):17-19. PubMed ID: 22796835
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of malignant pleural effusions.
    Antony VB; Loddenkemper R; Astoul P; Boutin C; Goldstraw P; Hott J; Rodriguez Panadero F; Sahn SA
    Eur Respir J; 2001 Aug; 18(2):402-19. PubMed ID: 11529302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.